Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONQUER-DVT Pilot
NCT06440694Phase 3Recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jul 2025
- Primary completion
- Dec 2027
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in deep vein thrombosis (DVT), sponsored by Ottawa Hospital Research Institute. Started Jul 2025; status: recruiting.
02
Drugs
colchicine
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT06440694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06440694.